eLifeNeurosciencePeer-reviewed journal article
Effects of dopamine D2 and opioid receptor antagonism on the trade-off between model-based and model-free behavior in healthy volunteers
Nace MikušiD, Sebastian KorbiD, Claudia MassaccesiiD, Christian GaustereriD, Irene GrafiD, Matthäus WilleitiD, Christoph EiseneggeriD, Claus LammiD, Giorgia SilaniiD, Christoph D. MathysiD
Abstract
Our daily behaviour requires a flexible arbitration between actions we do out of habit and actions that are directed towards a specific goal. Drugs that target opioid and dopamine receptors are notorious for inducing maladaptive habitual drug consumption, yet how the opioidergic and dopaminergic neurotransmitter systems contribute to the arbitration between habitual and goal-directed behaviour is poorly understood. By combining pharmacological challenges with a well-established decision-making task and a novel computational model, we show that the administration of the D2 dopamine receptor antagonist amisulpride led to an increase in goal-directed or model-based relative to habitual or model-free behaviour, whereas the non-selective opioid receptor antagonist naltrexone had no appreciable effect. These findings highlight the distinct functional contributions of dopamine and opioid receptors to goal-directed and habitual behaviour and support the notion that D2 receptor antagonists promote stabilisation of goal-relevant information.
- Citations
- 17
- FWCI
- 1.55
- Field percentile
- top 18%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Opioid antagonism reduces wanting by strengthening frontostriatal connectivity
Alexander Soutschek, Susanna C. Weber, … Philippe N. Tobler·eLifePeer-reviewed·Nov 11, 2021
- Effects of dopamine and opioid receptor antagonism on the neural processing of social and non-social rewards
Claudia Massaccesi, Sebastian Korb, … Giorgia Silani·Human Brain MappingPeer-reviewed·Mar 1, 2024
- Doing what's not wanted: Conflict in incentives and misallocation of behavioural control lead to drug-seeking despite adverse outcomes
Pranav Mahajan, Veeky Baths, Boris S Gutkin·Addiction NeurosciencePeer-reviewed·Jun 25, 2023
- A dopaminergic basis of behavioral control
Ian C. Ballard, Daniella J. Furman, … Mark D’Esposito·bioRxiv·Sep 17, 2024
- Cortical dopamine reduces the impact of motivational biases governing automated behaviour
Vanessa Scholz, Roxanne W. Hook, … Hanneke E.M. den Ouden·NeuropsychopharmacologyPeer-reviewed·Mar 8, 2022
- Bidirectional modulation of reward-guided decision making by dopamine
Ana Antonia Dias Maile, Theo O.J. Gründler, … Gerhard Jocham·PsychopharmacologyPeer-reviewed·May 29, 2025